Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Philip Hamann"'
Publikováno v:
RMD Open, Vol 9, Iss 4 (2023)
Remote patient monitoring (RPM) leverages advanced technology to monitor and manage patients’ health remotely and continuously. In 2022 European Alliance of Associations for Rheumatology (EULAR) points-to-consider for remote care were published to
Externí odkaz:
https://doaj.org/article/cfb4d5239d5c40d9be30b4b49757bd2f
Autor:
Philip, Hamann, Richard, Holland, Kimme, Hyrich, John D, Pauling, Gavin, Shaddick, Alison, Nightingale, Neil, McHugh
Publikováno v:
Arthritis careresearch. 69(6)
Anti-tumor necrosis factor (anti-TNF) antibody has revolutionized the treatment of rheumatoid arthritis (RA), and remission is now a realistic possibility for patients. Despite widespread use of anti-TNFs, predicting which patients are most likely to
Publikováno v:
Current Rheumatology Reviews. 6:208-215
Pain is a major symptom in rheumatic diseases. Understanding the nature of patients pain symptoms in a rheumatology setting is integral to their assessment and optimising care. In recent years we have increasingly come to appreciate that not only is
Autor:
Philip Hamann, Neil McHugh
Autoimmune serology has become central in the characterization of many rheumatic conditions and in many cases the presence of an autoantibody (e.g. anti-citrullinated peptide, rheumatoid factor, ANCA, ANA, ENA, anti-phospholipid antibody), may form p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c164916022ff8176df368f6724dd562
https://doi.org/10.1093/med/9780199642489.003.0063_update_003
https://doi.org/10.1093/med/9780199642489.003.0063_update_003
Publikováno v:
Emergency medicine journal : EMJ. 27(8)
There is increasing evidence for the use of Intralipid in the management of acute local anaesthetic toxicity. This is supported by the recent Association of Anaesthetists of Great Britain and Ireland (AAGBI) guidelines for the management of local ana